Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)

被引：0
|
作者：
Aygun, B [1 ]
Moore, JW [1 ]
Karayalcin, G [1 ]
机构：
[1] Schneider Childrens Hosp, Manhasset, NY USA
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1674
引用
收藏
页码：293A / 294A
页数：2
相关论文
共 50 条
  • [1] Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)
    Aygun, B
    Moore, JW
    Karayalcin, G
    BLOOD, 2002, 100 (11) : 28B - 28B
  • [2] Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease
    Ware, RE
    Zimmerman, SA
    Schultz, WH
    BLOOD, 1999, 94 (09) : 3022 - 3026
  • [3] Role of hydroxyurea (HU) in children with sickle cell disease (SCD)
    Motwani, J
    Lawson, SE
    Darbyshire, PJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 24 - 25
  • [4] Influence of Duffy blood type on hydroxyurea (HU) therapy in pediatric sickle cell disease (SCD) patients.
    Raphael, R
    OheneFrempong, K
    Horiuchi, K
    BLOOD, 1997, 90 (10) : 1972 - 1972
  • [5] Stroke Risk In Children with Sickle Cell Disease (SCD) Treated by Hydroxyurea (HU). A Belgian Center Experience
    Lefevre, Nicolas
    Dufour, Dominique
    Gulbis, Beatrice
    Le, Phu-Quoc
    Heijmans, Catherine
    Devalck, Christine
    Huybrechts, Sophie
    Ferster, Alina
    BLOOD, 2010, 116 (21) : 1091 - 1091
  • [6] Hydroxyurea (HU) therapy improves cognitive functioning in sickle cell disease (SCD) patients.
    Bernaudin, F
    Freard, F
    Lesprit, E
    Roudot-Thoraval, F
    Verlhac, S
    Benkerrou, M
    Thuret, I
    Mardini, R
    Vannier, JP
    Ploix, E
    Romero, M
    Casse-Perrot, C
    Helly, M
    Gillard, E
    Brugieres, P
    Reinert, P
    BLOOD, 1999, 94 (10) : 416A - 417A
  • [7] Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?
    Galacteros, Frederic
    Voskaridou, Ersi
    Habibi, Anoosha
    Cannas, Giovanna
    Joseph, Laure
    Loko, Gylna
    De Montalembert, Mariane
    Elenga, Narcisse
    Benkerrou, Malika
    BLOOD, 2020, 136
  • [8] Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza, A
    Bisotti, R
    Gonzalez, S
    Costa, M
    Hernandez, M
    Pinto, S
    Sumoza, D
    Fairbanks, VF
    BLOOD, 1998, 92 (10) : 35B - 35B
  • [9] Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)
    Sumoza, A
    de Bisotti, R
    Sumoza, D
    Fairbanks, V
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (03) : 161 - 165
  • [10] Chronic Administration of Hydroxyurea (HU) and Outcomes in Patients with Sickle Cell Disease (SCD) at a Single Referral Institution
    Di Maggio, Rosario
    Hsieh, Matthew
    Fitzhugh, Courtney
    Zhao, Xiongce
    Calvaruso, Giusi
    Rigano, Paolo
    Renda, Disma
    Siragusa, Sergio
    Tisdale, John F.
    Maggio, Aurelio
    BLOOD, 2014, 124 (21)
12345